Copyright West LLC. Minimum 15 minutes delayed.

Investors & Media

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Dicerna Closes $25 Million Series B Financing View HTML
Toggle Summary Dicerna Selected as Top Biotech to Watch for Windhover's 2010 Euro-Biotech Forum View HTML
Toggle Summary Dicerna Data Highlighted at ASCO by UCSF Cancer Researcher Frank McCormick during Plenary Session View HTML
Toggle Summary Dicerna names Douglas Fambrough as Chief Executive Officer View HTML
Toggle Summary Dicerna Pharmaceuticals and Ipsen Enter into an Exclusive Research Collaboration for the Development of New Therapeutic Agents in Endocrinology and Oncology View HTML
Toggle Summary Dicerna Signs Research Collaboration and License Agreement for Drug Delivery Systems and Dicer Substrate siRNA (DsiRNA) Pharmaceuticals with Kyowa Hakko Kirin View HTML
Toggle Summary Dicerna Pharmaceuticals to Present at 2009 Biologics Drug Delivery & Beyond Conference View HTML
Toggle Summary Dicerna Pharmaceuticals to Present at Upcoming Conferences View HTML
Toggle Summary Dicerna Pharmaceuticals Scientific Founder To Present Data Demonstrating Dual Inhibitory Function of Aptamer-Dicer Substrate siRNA Conjugates at Oligonucleotide Therapeutics Conference View HTML
Toggle Summary Archemix and Dicerna to Collaborate on Conjugated Aptamer-Dicer Substrate RNAi Therapeutics View HTML